发明名称 |
METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT |
摘要 |
The invention relates to methods for preventing, slowing the progression of, delaying or treating metabolic disorders induced in patients by the treatment with neuroleptic agents comprising administering to the patients an SGLT2 inhibitor. |
申请公布号 |
US2016074415(A1) |
申请公布日期 |
2016.03.17 |
申请号 |
US201514949986 |
申请日期 |
2015.11.24 |
申请人 |
Boehringer Ingelheim International GmbH |
发明人 |
WIENRICH Marion;MAYOUX Eric Williams |
分类号 |
A61K31/5513;A61K31/381;A61K31/351;A61K31/551;A61K31/4515 |
主分类号 |
A61K31/5513 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for preventing, slowing the progression of, delaying or treating a metabolic disorder induced in a patient by the treatment of said patient with a neuroleptic agent, said method comprising administering to said patient an SGLT2 inhibitor and a neuroleptic agent, wherein said SGLT-2 inhibitor and said neuroleptic agent are administered in combination or alternation or sequentially to the patient, wherein said SGLT2 inhibitor is empagliflozin, dapagliflozin or canagliflozin and wherein said neuroleptic agent is olanzapine, haloperidol or clozapine. |
地址 |
Ingelheim am Rhein DE |